Close menu




July 22nd, 2024 | 06:45 CEST

Palantir, VCI Global, C3.ai - Beneficiaries of the megatrend

  • AI
  • Fintech
  • Software
  • Technology
Photo credits: pixabay.com

The emergence of ChatGPT brought artificial intelligence into the mainstream. Since then, companies developing various AI services have been springing up like mushrooms. This trend will undoubtedly continue to gain momentum in the future, as various technologies are already too firmly anchored in the economy and society. Despite the current sideways movement on the stock markets, we should continue to keep an eye on the developments of listed players who are likely to benefit from this super cycle in the future.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: PALANTIR TECHNOLOGIES INC | US69608A1088 , VCI GLOBAL LIMITED | VGG982181031 , C3.AI INC | US12468P1049

Table of contents:


    Palantir - A key player in the AI revolution

    Controversial or not, data analysis specialist Palantir is, without a doubt, one of the favourites for the next AI wave. The reason is obvious. The Denver-based company has the ability to integrate and analyze vast amounts of data from various sources. Its platforms, such as Palantir Foundry and Palantir Gotham, enable companies and government organizations to understand complex data landscapes and make informed decisions.

    In addition, the Company, led by Alex Karp, delivers scalable AI solutions tailored to its customers' specific needs. These solutions can process and analyze large amounts of data to provide valuable insights.

    In a recent study, the analysts at Wedbush highlighted the great potential that Palantir's shares offer at the current level of USD 28.58, giving them a price target of USD 50 for the year 2025 with an "Outperform" rating.

    "With artificial intelligence (AI) spending taking up more space in IT budgets as more organizations learn how to properly deploy this technology, we believe Palantir is in a prime position to expand its pipeline further as the Company delivers more use cases," Wedbush said.

    VCI Global continues to expand

    Malaysia-based diversified holding company VCI Global, which focuses on consulting, fintech, AI, robotics, and cybersecurity, is still relatively unknown. However, the Company, which is capitalized with just under USD 40 million, has big plans to strengthen its global presence and expand its business areas.

    In addition to the start of the dual listing on the Frankfurt Stock Exchange, VCI Global, which is headquartered in Kuala Lumpur, has made several significant announcements in recent weeks. An agreement was signed to invest up to USD 30 million in TalkingData Group, a leading provider of big data analytics and AI-powered solutions. TalkingData supplies global brands such as Google, Yahoo, L'Oréal, PepsiCo, and Nike and plans to list on the US market in the near future. A cooperation with VCI Global is of great value here, as the TalkingData Group can utilize their expertise in the capital markets as well as in technology, especially in Southeast Asia.

    The latest coup was the announcement of a strategic joint venture with Frankfurt-based Cogia AG, which specializes in artificial intelligence and secure communication solutions. The new entity will be named AiSecure Limited, with VCI owning 70% of the Company and being the sole owner of Cogia's secure messenger platform for governments and security-related organizations. Cogia will lead future development, including the integration of secure AI technology into the messenger. The two partners aim to develop AiSecure over the next 12-18 months to meet NASDAQ listing requirements.

    C3.ai - Tackling growing bureaucracy

    Who among us is not frustrated by the ever-growing bureaucracy, lack of information on new citizen programs, or wait times for seemingly easy-to-solve problems with services such as applying for an ID card, transferring a vehicle registration document, etc.?

    C3.ai, led by Tom Siebel, who sold Siebel Systems to Oracle years ago, specializes in AI application software for businesses and is now declaring war on the high bureaucratic hurdles with the launch of "C3 Generative AI for Government Programs". The program provides a generative AI application that helps federal, state, and local governments quickly provide the public with accurate information about government programs ranging from healthcare to employment to financial assistance.

    The goal is to eliminate service delays, shorten wait times, make contact centers more effective, and improve the citizen experience. By enabling the public to find answers directly through an intuitive search and chat interface, support centers are expected to receive fewer inquiries and be less burdened, allowing service staff to focus on more complex cases and inquiries.

    The shares of the Company, valued at USD 3.38 billion, have risen by more than 37% to USD 27.83 after hitting a low of USD 20.23 in April. A significant resistance level is currently at USD 32.56, where the downward trend that has been in place since June 2023 is located. If this is broken, the price should move relatively quickly towards the USD 38.30 range.


    Artificial intelligence has become an integral part of our lives. The data analysis company Palantir, which has been awarded a significant price target increase by analysts, plays a key role. C3.ai announced the launch of its C3 Generative AI platform, which makes communication with administrations much easier. VCI Global continues to strengthen its presence and has significantly expanded its market position in recent weeks.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Armin Schulz on October 17th, 2025 | 07:05 CEST

    Three stocks, one trend: Jump on the momentum bandwagon with Almonty Industries, AMD, and ASML

    • Mining
    • Tungsten
    • hightech
    • AI
    • semiconductor
    • chips

    The stock market often rewards those who recognize a trend before it becomes mainstream. This is not about short-term speculation, but about identifying companies with strong fundamental tailwinds that can drive prices higher over the long term. This momentum is fueled by structural factors: global technology shifts, geopolitical realignments, and the reorganization of critical supply chains. There is a reason why the saying goes: Go with the flow! Almonty Industries, AMD, and ASML each embody these powerful forces and currently have strong momentum on their side. Let's take a closer look.

    Read

    Commented by Armin Schulz on October 16th, 2025 | 07:20 CEST

    Investors take note: BioNxt Solutions builds on blockbusters from Novo Nordisk and Merck - and has another ace up its sleeve in oncology

    • Biotechnology
    • Biotech
    • Pharma
    • Cancer
    • blockbuster
    • Technology

    In the biotech sector, a single technology can often determine success or failure. Canadian-German company BioNxt Solutions is taking a different approach, relying on three pillars, each targeting major markets and advancing established blockbusters from leading pharmaceutical companies. October has already brought decisive progress, from accelerated patent protection to concrete milestones in development. These concentrated positive signals show that BioNxt Solutions not only has a promising concept, but also the strategy and operational strength to turn it into value. A closer analysis is worthwhile.

    Read

    Commented by Fabian Lorenz on October 16th, 2025 | 07:05 CEST

    Takeover fever and AI Opportunities: BioNTech, Novo Nordisk, PanGenomic Health

    • Biotechnology
    • AI
    • healthtech
    • Sustainability
    • plantbased

    The pharmaceutical and biotech sector is buzzing with takeover activity. Following the announcement of a billion-dollar acquisition in the US, Novo Nordisk has announced its next deal, eyeing a potential best-in-class therapeutic for several rare diseases. Meanwhile, PanGenomic Health is positioning itself in the billion-dollar market for alternative medicine and dietary supplements, leveraging AI to provide added value to customers and capture market share. If successful, the stock could be significantly undervalued. BioNTech's acquisition of CureVac has now been completed, ending CureVac's period of suffering. In the process, BioNTech secures patents and elegantly resolves ongoing legal disputes.

    Read